Webinars

Based on our DecisionBase 2010 report entitled Psoriasis: Dermatologists Identify Remaining Opportunities as the Number of Highly Efficacious Biologics Continues to Grow, Decision Resources is offering an exclusive webinar entitled What Key Drug Attributes Will Emerging Therapies Need to Erode the Dominance of TNF-alpha Inhibitors in Moderate to Severe Psoriasis? Because this webinar will feature major report findings, it is ONLY available to purchasers of this report.

This webinar will be held on March 31, 2010. Contact us to learn how you can purchase this report and attend the webinar. 

Click here to view the invite.
 

Based on our report entitled Strategic Overview of Pricing and Reimbursement in the BRIC Markets, Decision Resources is offering an exclusive webinar entitled Building in BRIC—Negotiating the Challenges and Capitalizing on the Opportunities in Emerging Markets.  Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on March 18, 2010. Contact us to learn how you can purchase this report and and access a recorded playback of this event.

Click here to view the invite.
 

Based on our DecisionBase 2010 report entitled Obesity: A Novel Oral Therapy Emerges That Delivers Superior Weight-Loss Efficacy, Decision Resources is offering an exclusive webinar entitled Will the Lack of Efficacious Therapies Open the Door for a New Clinical Gold Standard in Obesity Treatment? Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on March 17, 2010. Contact us to learn how you can purchase this report and and access a recorded playback of this event.

Click here to view the invite.
 

Based on our DecisionBase 2010 report entitled Type 2 Diabetes: Despite the Domination of Entrenched, Generic Oral Therapies, Blockbuster Potential Awaits a Once-Weekly GLP-1 Analogue, Decision Resources is offering an exclusive webinar entitled Exploring Current Unmet Needs in Type 2 Diabetes: What Impact Will Long-Acting GLP-1 Analogues Have? Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on March 10, 2010. Contact us to learn how you can purchase this report and and access a recorded playback of this event.

Click here to view the invite.
 

Decision Resources is offering an exclusive Pharmaview competitive assessment entitled Is Cerezyme’s Heyday Over? Shire and Pfizer/Protalix Are Poised to Challenge Genzyme’s Dominance in Gaucher’s Disease – But Will They Succeed? This session is ONLY available to Pharmaview subscribers.

This session was held on March 4, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.
 

Based on our report entitled, Strategic Overview of the Targeted Cancer Therapies Marketplace, Decision Resources is offering an exclusive webinar entitled The Targeted Cancer Therapies Industry: Will It Become a Victim of Its Own Success? Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on February 24, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.
 

Based on our DecisionBase 2010 report, Hepatitis C Virus Treatment Non-Responders: Hope on the Horizon with the Imminent Introduction of HCV-Targeted Therapeutics, Decision Resources is offering an exclusive webinar entitled Looking Beyond Triple Therapy for the Hepatitis C Non-Responders Population: U.S. and European Physician Expectations and Perceptions About Quadruple Therapy. Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on February 18, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.
 

Based on our DecisionBase 2010 report, Rheumatoid Arthritis: Opportunity Awaits Therapies That Meet Physicians’ Efficacy Expectations in TNF-α Inhibitor-Refractory Patients, Decision Resources is offering an exclusive webinar entitled Can Your Drug Gain An Edge in the TNF-Alpha Refractory Patient Segment of the Rheumatoid Arthritis Market? Exploring Drug Attributes Needed to Maximize Patient Share. Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on January 27, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.
 

Based on our Special European Physician & Payer Forum report entitled Metastatic Colorectal Cancer in Europe: Changing Dynamics in Light of Increasing Segmentation and New Therapeutic Options, Decision Resources is offering an exclusive webinar entitled Erbitux is Poised to Threaten Avastin’s Dominance in Early Lines of Treatment for Colorectal Cancer in Europe. Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on December 16, 2009. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.
 

Based on our 2009 Industry Report Biosimilars: TNF-Alpha Inhibitors and Interferon-Alphas in Immune and Infectious Disease, Decision Resources is offering an exclusive webinar entitled Despite Physicians' Conservative Attitude Towards Biosimilars, TNF-Alpha Inhibitors Stand to Lose $22 Billion in Sales. Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on December 3, 2009. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.